The Peripherally Inserted Central Catheter (PICC) Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Peripherally Inserted Central Catheter (PICC) Market:
https://www.thebusinessresearchcompany.com/report/peripherally-inserted-central-catheter-picc-global-market-report
According to The Business Research Company’s Peripherally Inserted Central Catheter (PICC) Global Market Report 2024, The peripherally inserted central catheter (PICC) market size is expected to see steady growth in the next few years. It will grow to $1.32 billion in 2028 at a compound annual growth rate (CAGR) of 5.17%. The growth in the forecast period can be attributed to expansion of interventional radiology practices, focus on infection prevention and control, rising healthcare expenditure, patient-centered care initiatives. Major trends in the forecast period include technological advancements, personalized medicine, minimally invasive procedures, integration of digital health technologies, regulatory compliance and standardization.
The growing prevalence of chronic diseases is expected to propel the growth of the peripherally inserted central catheter market in the coming years. Chronic diseases refer to long-term health conditions that persist over an extended period and often progress slowly, such as cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, obesity, and oral diseases. Peripherally inserted central catheters (PICCs) are employed in chronic conditions to provide long-term intravenous access to drugs, fluids, parenteral nutrition, and blood draws. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of individuals aged 50 years and older having one or more chronic illnesses is projected to rise by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. Therefore, the growing prevalence of chronic diseases is driving the growth of the peripherally inserted central catheter (PICC) market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13908&type=smp
The peripherally inserted central catheter (picc) market covered in this report is segmented –
1) By Device Type: Power-Injectable, Non-Power Injectable
2) By Lumen Type: Single, Double, Triple
3) By Kit Type: Tip-Placement Kit, Conventional Kit
4) By End User: Hospitals and Clinics, Ambulatory Surgical Centers, Catheterization Laboratories
Major companies operating in the peripherally inserted central catheter (PICC) market are focused on innovative technologies, such as peripherally inserted central catheter insertion devices, to better serve their customers with advanced features. Peripherally inserted central catheter insertion devices are medical instruments specifically designed for the placement of peripherally inserted central catheters (PICCs) to insert them into a peripheral vein, typically in the arm, and guide them through the vasculature until the tip reaches a larger vein near the heart. For instance, in May 2023, Teleflex Incorporated, a US-based medical device company, launched two new peripherally inserted central catheter insertion devices, the Arrow VPS Rhythm DLX Device and the NaviCurve Stylet. The VPS Rhythm DLX Device uses cardiac electrical activity to offer real-time catheter tip position information. The device also has an optional integrated ultrasonography with a catheter-to-vessel ratio tool that supports consistency in vessel measuring. This gadget, in conjunction with the Arrow PICC packed with the NaviCurve Stylet, provides new tip navigation or location technology. The VPS Rhythm DLX Device featuring TipTracker Technology removes the necessity for a confirmatory x-ray, allowing the physician to insert smoothly via ultrasound vascular evaluation, peripherally inserted central catheter navigation, and final tip verification in the bottom third of the superior vena cava.
The peripherally inserted central catheter (picc) market report table of contents includes:
- Executive Summary
- Peripherally Inserted Central Catheter (PICC) Market Characteristics
- Peripherally Inserted Central Catheter (PICC) Market Trends And Strategies
- Peripherally Inserted Central Catheter (PICC) Market – Macro Economic Scenario
- Global Peripherally Inserted Central Catheter (PICC) Market Size and Growth
.
.
.
- Global Peripherally Inserted Central Catheter (PICC) Market Competitive Benchmarking
- Global Peripherally Inserted Central Catheter (PICC) Market Competitive Dashboard
- Key Mergers And Acquisitions In Peripherally Inserted Central Catheter (PICC) Market
- Peripherally Inserted Central Catheter (PICC) Market Future Outlook and Potential Analysis
- Appendix
Top Major Players :
- Cardinal Health Inc.
- Medtronic plc
- Becton Dickinson and Company
- Boston Scientific Corporation
- Braun Medical Ltd
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
